Comerica Bank
NAVB

Comerica Bank’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Comerica Bank’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-547
Closed -$20K – 2257
2014
Q1 		$20K Buy
547
+10
+2% +$379 ﹤0.01% 2280
2013
Q4 		$22K Hold
537
– – ﹤0.01% 2256
2013
Q3 		$28K Buy
+537
New +$31.3K ﹤0.01% 2581

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Comerica Bank's NAVB Position: Q2 2014 in Review

Comerica Bank sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2014, closing a stake of 547 shares — an estimated $20K sold.

Comerica Bank first reported a position in NAVB in Q3 2013 and held it in 3 quarters. The position peaked at $28K in Q3 2013. 87 funds tracked by Wall St. Rank hold NAVB as of Q2 2014.

  • Comerica Bank reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2014 after selling out during the quarter.
  • Comerica Bank sold 547 Navidea Biopharmaceuticals Inc. shares in Q2 2014, an estimated $20K.
  • Comerica Bank first reported a position in Navidea Biopharmaceuticals Inc. in Q3 2013 and held it in 3 quarters.
  • Comerica Bank's Navidea Biopharmaceuticals Inc. position peaked at $28K in Q3 2013.
  • 87 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2014.

Based on Comerica Bank's 13F filing for Q2 2014, filed 12 Aug 2014.